Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Dachau – page 45

1 447 clinical trials in Dachau, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Dachau at a glance
1 447
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 447 trials in Dachau

Open in trial search

Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Faecal Microbiota, Pooled
  • Sponsor:Maat Pharma

Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes

Ewing's sarcoma

Recruiting

Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:GPOH gGmbH

Study of ONC201 for Patients with Newly Diagnosed H3 K27M-mutant Diffuse Glioma After Radiotherapy

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dordaviprone
  • Sponsor:Chimerix Inc.

Study on Ivosidenib for Patients with Previously Treated Advanced or Metastatic Cholangiocarcinoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivosidenib
  • Sponsor:Servier Affaires Medicales

Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Study on the Effects of Rituximab for Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.

Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study on the Effects of XEN1101 and Placebo for Patients with Primary Generalized Tonic-Clonic Seizures

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Azetukalner
  • Sponsor:Xenon Pharmaceuticals Inc.

Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lixudebart
  • Sponsor:Alentis Therapeutics AG

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Crohn's disease

Recruiting

Study on INTESTIFIX for Maintaining Remission in Children and Adults with Crohn's Disease After Exclusive Enteral Nutrition Treatment

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Intestifix
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Dachau

What the registry says about research in the country

01 Respiratory Medicine

Research focusing on respiratory syncytial virus (RSV) and chronic obstructive pulmonary disease, evaluating innovative treatment approaches and preventive measures.

  • RSV vaccination studies in older adults
  • COPD treatment optimization
  • Respiratory therapy combinations

Advanced trials investigating both preventive vaccines and therapeutic interventions for respiratory conditions.

02 Gastroenterology

Comprehensive studies addressing inflammatory bowel diseases, including breakthrough treatments for ulcerative colitis and Crohn's disease.

  • Novel therapeutic approaches for UC
  • Crohn's disease management
  • Combination therapy investigations

Multiple innovative treatments being evaluated to improve patient outcomes in inflammatory bowel conditions.

03 Cardiovascular Medicine

Critical research in atrial fibrillation and related cardiovascular conditions, exploring new therapeutic strategies and prevention methods.

  • Cardioembolic event prevention
  • Acute coronary syndrome management
  • Anticoagulation therapy optimization

Innovative approaches to cardiac care and stroke prevention in high-risk patients.

04 Hematology

Advanced research in chronic lymphocytic leukemia, particularly focusing on high-risk patients with specific genetic markers.

  • Triple combination therapy evaluation
  • Treatment of high-risk CLL
  • Novel therapeutic approaches

Cutting-edge treatments targeting specific genetic mutations in blood disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.